| Business Summary |
| A specialty pharmaceutical company, which is focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. |
| General Information |
3180 Porter Drive
Palo Alto, CA 94304
|
| www.jazzpharmaceuticals.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 216 |
| CEO: Bruce C. Cozadd |
| Short Interest |
| Current Month (Mil) |
2.04 |
| Previous Month (Mil) |
2.14 |
| Short Interest Ratio (Days) |
2.70 |
| Management Effectiveness |
| Return on Equity |
N.A. |
| Return on Assets |
-68.00 |
| Return on Investments |
-210.00 |
| Profitability |
| Gross Margin |
92.10 |
| EBIT Margin |
-42.80 |
| Profit Margin |
-63.30 |